TABLE 3.

Clinical symptoms reported in AFDUC patients upon enrollment from January to June, 2019–2020.

Sign	SINV positive N = 38	SINV negative N = 159	Odds ratio	bP-value
Fatigue	29 (76.3%)	109 (68.6%)	1.48[0.65–3.35]	0.3
Headache	22 (57.9%)	60 (37.7%)	2.27[1.11–4.66]	<0.05
Chills	9 (23.7%)	40 (25.2%)	0.92[0.40–2.12]	0.9
Weight loss	9 (23.7%)	50 (31.5%)	0.68[0.30–1.54]	0.3
Meningitis	21 (55.3%)	52 (32.7%)	2.54[1.24–5.22]	<0.05
Acute flaccid paralysis	2 (5.3%)	17 (10.7%)	0.46[0.10–2.10]	0.3
Seizure	11 (28.9%)	58 (36.5%)	0.71[3.33–1.54]	0.4
Arthralgia	8 (21.1%)	15 (9.4%)	2.56[1.00–6.58]	<0.05
aDermatological signs	7 (18.4%)	22 (13.8%)	1.41[0.55–3.58]	0.5
Fever	15 (39.5%)	70 (44.0%)	0.83[0.4–1.71]	0.6
Nausea	8 (21.1%)	18 (11.3%)	2.09[0.83–5.25]	0.11
HIV positive	12 (31.8%)	37 (23.3%)	1.52[0.70–3.31]	0.3

The percentage (%), 95.0% Confidence interval (CI) and P-value is also indicated.

^aDermatological signs: Pruritus (itching), Skin rash, Skin patches.

^bP-values less than 0.05 is regarded as significant.

P values < 0.05 are statistically significant.